Status:
COMPLETED
A Dose Finding Study Of PF-00489791 In Patients With Mild To Moderate High Blood Pressure
Lead Sponsor:
Pfizer
Conditions:
Hypertension
Eligibility:
All Genders
18-70 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to evaluate the safety and blood pressure lowering effect of different doses of PF-00489791 in patients with mild to moderate high blood pressure
Eligibility Criteria
Inclusion
- Males and/or Females of non-childbearing potential between 18 and 70 years of age
- History of mild to moderate hypertension
Exclusion
- Type 1 or 2 diabetes on prescribed medications
- Secondary, severe, or malignant hypertension
- History of a significant cardiovascular event within the last 12 months of enrollment
Key Trial Info
Start Date :
February 27 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 28 2008
Estimated Enrollment :
135 Patients enrolled
Trial Details
Trial ID
NCT00422461
Start Date
February 27 2007
End Date
January 28 2008
Last Update
October 11 2021
Active Locations (20)
Enter a location and click search to find clinical trials sorted by distance.
1
National Research Institute
Los Angeles, California, United States, 90057
2
Apex Research Institute
Santa Ana, California, United States, 92705
3
Orange County Research Center
Tustin, California, United States, 92780
4
University of Connecticut Health Center
Farmington, Connecticut, United States, 06030-3940